Edition:
United States

Genetic Technologies Ltd (GTG.AX)

GTG.AX on Australia Stock Exchange

0.02AUD
26 Jul 2016
Change (% chg)

$0.00 (+5.26%)
Prev Close
$0.02
Open
$0.02
Day's High
$0.02
Day's Low
$0.02
Volume
100,000
Avg. Vol
842,682
52-wk High
$0.04
52-wk Low
$0.02

GTG.AX

Chart for GTG.AX

About

Genetic Technologies Limited is a molecular diagnostics company. The Company offers predictive testing and assessment tools to help physicians manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to... (more)
No analyst recommendations are available for GTG.AX.

Overall

Beta: 1.18
Market Cap(Mil.): $32.59
Shares Outstanding(Mil.): 1,715.28
Dividend: --
Yield (%): --

Financials

  GTG.AX Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -0.01 -- --
ROI: -93.04 -5.86 14.35
ROE: -102.28 -4.70 15.56

BRIEF-SUNJIN to buy 67.42 pct stake in GENETIC RESOURCES

* Says it plans to buy 67.42 percent stake (156,221 shares) in GENETIC RESOURCES CO., LTD, for 24.90 billion won

May 30 2016

BRIEF-Genetic Technologies files for mixed shelf of up to $100 mln

* Files for mixed shelf of up to $100 million - sec filing Source text : http://1.usa.gov/26xfduO Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)

Apr 28 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.